News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Happel David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
3
| Happel David (President & CEO) has filed a Form 3 on Sagimet Biosciences Inc. |
| 10/26/2017 |
4
| Happel David (EVP, Commercial Dev & Strategy) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Paid exercise price by delivering 4,150 shares
@ $13.53, valued at
$56.1k
Exercised 7,953 restricted stock units
@ $0 |
|
| 11/07/2016 |
3
| Happel David (EVP Global Orphan Bus. Unit) has filed a Form 3 on Horizon Pharma plc |
| 10/26/2016 |
4
| Happel David (Chief Commercial Officer) has filed a Form 4 on Raptor Pharmaceutical Corp|
Txns:
| Unknown transaction of 8,934 shares
@ $9, valued at
$80.4k
Disposed/sold 28,939 shares
@ $9, valued at
$260.5k
Disposed/sold 93,784 options to buy
@ $3.74, valued at
$350.8k
|
|
| 03/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|